ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD.

All News Zhejiang Huahai Pharmaceutical Co., Ltd.

Equities

600521

CNE000001DL5

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-14 pm EDT			5-day change	1st Jan Change
17.39 ^CNY	-0.34%		-1.25%	+18.54%

May. 13	Huahai Pharmaceutical's Unit Gets Nod to Register Atomoxetine Hydrochloride Oral Solution	MT
May. 02	Huahai Pharmaceutical's Q1 Profit Jumps 57%, Income Up 21%	MT

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Huahai Pharmaceutical's Unit Gets Nod to Register Atomoxetine Hydrochloride Oral Solution	May. 13	MT
Huahai Pharmaceutical's Q1 Profit Jumps 57%, Income Up 21%	May. 02	MT
Zhejiang Huahai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 29	CI
Huahai Pharmaceutical Gets Approval to Market Busulfan Injection	Apr. 23	MT
Tranche Update on Zhejiang Huahai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on November 14, 2023.	Apr. 18	CI
Zhejiang Huahai Pharmaceutical Gets Chinese Registration Nod for Torsemide Tablets	Apr. 17	MT
Zhejiang Huahai Pharmaceutical Co., Ltd.'s Equity Buyback announced on November 14, 2023 has closed with 7,023,600 shares, representing 0.48% for CNY 99.99 million.	Apr. 16	CI
Zhejiang Huahai Pharmaceutical Forecasts Up to 65% Rise in Q1 Profit	Apr. 16	MT
Shyndec Pharmaceutical's Unit Gets Nod to Register Empagliflozin Tablets	Apr. 16	MT
Zhejiang Huahai Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 15	CI
Tranche Update on Zhejiang Huahai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on November 14, 2023.	Apr. 01	CI
Tranche Update on Zhejiang Huahai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on November 14, 2023.	Jan. 02	CI
Zhejiang Huahai Pharmaceutical Gets US FDA's Nod for Pemetrexed Disodium for Injection	Dec. 18	MT
Correction: Huahai Pharmaceutical Gets Nod to Amend Specifications for Irbesartan Tablets	Dec. 11	MT
Huahai Pharmaceutical Gets Nod to Amend Spefication for Irbesartan Tablets	Dec. 11	MT
Zhejiang Huahai Pharmaceutical Co., Ltd. announces an Equity Buyback for CNY 100 million worth of its shares.	Nov. 13	CI
Huahai Pharma Selling 1.4 Billion Yuan Shares For Capacity Expansion	Nov. 10	MT
Huahai Pharma to Repurchase Up to 100 Million Yuan Shares	Nov. 06	MT
Huahai Pharma Unit Gets FDA Nod to Trial Cancer Drug	Nov. 06	MT
Zhejiang Huahai Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	Nov. 05	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Zhejiang Huahai Pharmaceutical Co., Ltd.

Equities

600521

CNE000001DL5

All News

Filters